Patent ID: 11951095
Assignee: PHARMAJOR INTERNATIONAL
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 19:
20. A method for reversible, continuous non-hormonal contraception in a male subject, the method comprising administering once daily at about the same time, a dose of a composition comprising:
(i) an extended release formulation of (R)-silodosin in an amount of about 4 mg to about 30 mg, the amount effective, when administered once daily at about the same time, to induce a reversible condition of aspermia, azoospermia or severe oligozoospermia sufficient for contraceptive effect in the male subject; and
(ii) a pharmaceutically acceptable carrier,
wherein once daily administration of the formulation at about the same time provides a reversible contraceptive effect, but does not cause discomfort upon ejaculation in the male subject.